This brings new hopes for patients with solid organ tumours. Currently, the CAR-T option is available for specific form of blood cancer since an indigenously developed innovation, NexCar-19, by ImmunoACT, is approved for treatment.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/hJZ6cu0
0 Comments